Acquirer Profile
UCB Acquisitions & Deals (2026)
Biopharmaceutical
Deals tracked
1
Combined value
$1.1B
Primary sector
Biopharmaceutical
Active
2026
FireStrike tracks every UCB acquisition, merger, and strategic investment in real time. This page covers 1 UCB deals totaling $1.1B in disclosed deal value, spanning Biopharmaceutical. Data covers 2026.
UCB Acquisitions — Full List
| Target company | Announced | Source |
|---|---|---|
Neurona Therapeutics Biopharmaceutical | Apr 2026 |
UCB Acquisitions — FAQ
How many acquisitions has UCB made?
UCB has made 1 acquisitions and deals tracked on FireStrike, totaling $1.1B in combined deal value.
What sectors does UCB acquire in?
UCB primarily acquires in Biopharmaceutical.
What is UCB's most recent acquisition?
UCB's most recent tracked acquisition is Neurona Therapeutics for $1.15B, announced Apr 2026.
Get every UCB deal in your inbox
FireStrike tracks M&A, IPOs, and fundraises daily — free.
Start tracking free →